Latest News at Universal Cells

Seattle Channel profiles Astellas’ Universal Cells employee competing in the 2018 Special Olympics USA Games

July 18th, 2018|0 Comments

For the past several months, 21-year-old Devon Adelman has served as an ambassador for Special Olympics, and she won a gold medal in the 2018 Special Olympics [...]

Astellas Acquires Universal Cells, Inc.

February 14th, 2018|0 Comments

Acquisition enables Astellas to fully utilize proprietary technology to produce pluripotent stem cells that have the potential to lower immunological rejection in numerous therapeutic areas Tokyo, February [...]

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology

October 20th, 2017|0 Comments

Tokyo, October 19, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Universal Cells, Inc. (CEO: Claudia Mitchell, “Universal Cells”) today announced [...]

Cell and Gene Therapy Catapult Licenses iPSC Line to Universal Cells to assist in the Development of Universal Donor Cell Line

October 5th, 2017|0 Comments

Universal Cells to utilise CGT Catapult’s induced Pluripotent Stem Cells to create universally accepted cells for research and commercial use London, UK, 5 October 2017 – The [...]

BlueRock Therapeutics and Universal Cells Enter Collaboration and License Agreement to Generate Gene-Edited iPS Cell Lines

October 3rd, 2017|0 Comments

CAMBRIDGE, MA and SEATTLE, WA, October 3, 2017-BlueRock Therapeutics and Universal Cells Inc. today announced that they have entered into a collaboration and license agreement to create [...]

Universal Cells to Present at 2017 Cell & Gene Meeting on the Mesa

September 18th, 2017|0 Comments

Seattle, WA September 18, 2017 – Universal Cells announced today that Claudia Mitchell, CEO will present at the annual Partnering Forum, part of the Cell & Gene [...]

Universal Cells’ CEO wins Leadership Award

May 30th, 2017|0 Comments

Seattle, WA – May 30th, 2017 – Universal Cells’ CEO and Co-founder, Claudia Mitchell received the Gold award in Leadership at the Seattle’s 3rd Annual French-American Business [...]

Universal Cells’ Gene Editing Strategy Published in Nature Biotechnology

May 15th, 2017|0 Comments

Seattle, WA – May 15th, 2017 – Universal Cells announced today that a report from Universal Cells’ CSO Dr. David Russell and researchers at the [...]

Universal Cells to present at 5th Annual Cell & Gene Therapy Investor Day, April 27th in Boston

April 20th, 2017|0 Comments

Seattle, WA – Universal Cells announced today that Claudia Mitchell, CEO will present at the Alliance for Regenerative Medicine’s 5th Annual Cell & Gene Therapy [...]

Dr. Bryan Steadman to join Universal Cells Inc. as Chief Technology Officer

March 1st, 2017|0 Comments

Seattle, WA – Universal Cells Inc. ( has announced that Dr. Bryan Steadman has joined the company as Chief Technology Officer.  He is responsible for the translation [...]

Claudia Mitchell is honored at annual Life Sciences Innovation Northwest Conference

June 1st, 2016|0 Comments

Universal Cells' CEO, Dr. Claudia Mitchell has received the 2016 Women in Life Sciences Award at the Life Science Innovation Northwest (LSINW) Conference. The LSINW Women in [...]

Universal Cells Inc. and Healios K.K. enter Collaborative Research Agreement with Exclusive Option to Produce Universal Donor iPSCs

April 6th, 2016|0 Comments

Seattle, WA-Universal Cells Inc. (Seattle WA, USA) and HEALIOS K.K. (“Healios”) (Tokyo, Japan) have entered into a collaborative research and exclusive option agreement to create therapeutic off-the-shelf [...]

Adaptimmune and Universal Cells announce Collaboration to Develop Allogeneic T-Cell Therapies

December 15th, 2015|0 Comments

Adaptimmune offices in Philadelphia PHILADELPHIA, PA. and OXFORD, UK, December 1, 2015 – Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of TCR [...]

Universal Cells will be attending the 2015 Stem Cell Meeting on the Mesa

September 21st, 2015|0 Comments

The Universal Cells team will be attending the 2015 Stem Cell Meeting on the Mesa in San Diego, California. To schedule a meeting time in advance please [...]

Universal Cells is awarded phase II SBIR grant from the NIH

January 14th, 2015|0 Comments

Universal Cells has recently been awarded a Phase II SBIR Grant from the US National Institutes of Health (NIGMS). The award provides non-dilutive funding to carry out [...]

Universal Cells’ CSO is awarded University of Washington inventor of the year

October 18th, 2014|0 Comments

David Russell, our CSO, was recognized as the 2014 Inventor of the Year at the University of Washington. Dr. Russell’s inventions have made a profound impact on [...]